Influenza Vaccine Live Intranasal Spray
NDC Package 66020-051-92

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Influenza Vaccine Live Intranasal sprays is a drug for further processing. This formulation utilizes a spray delivery system. Marketed by Medimmune, U.k. Limited, this product is identified by NDC 66020-051.

Identification & Billing

NDC Package Code
66020-051-92
Package Description
125 mL in 1 BOTTLE
Product Code
66020-051
11-Digit Billing Format
66020005192

Clinical Specifications

Proprietary Name
Influenza Vaccine Live Intranasal
Non-Proprietary Name
Influenza Vaccine Live Intranasal
Substance Name
Influenza A Virus; Influenza B Virus
Dosage Form
Spray - A liquid minutely divided as by a jet of air or steam.
Active Ingredient(s)

Regulatory & Marketing

Labeler Name
Medimmune, U.k. Limited
Product Type
Drug For Further Processing
Marketing Category
DRUG FOR FURTHER PROCESSING - A drug (other than the bulk ingredient API) that is in an interim stage of manufacture, processing, preparation, or packaging, and not ready for human or animal use.
Start Marketing Date
02-23-2007
Listing Expiration
12-31-2026
Exclude Flag
N
Unfinished Product
Yes
Sample Package
N/A

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 66020-051-92 identifies a specific commercial package of 125 ml in 1 bottle of Influenza Vaccine Live Intranasal (UNFINISHED drug), drug for further processing labeled by Medimmune, U.k. Limited. This spray is formulated for use and contains influenza a virus; influenza b virus as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Medimmune, U.k. Limited on February 23, 2007. The current certification is valid through December 31, 2026.

How is this Medimmune, U.k. Limited product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 66020005192. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
66020-051-92
11-Digit CMS (5-4-2)
66020-0051-92

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.